Komori
I'Ll Inc (3854) · InitiativeAdvanced

Upfront Investment in Product Development and Workforce Strengthening

First written in FY2016-Q3. 21 of 40 entries say "Restated". Latest entry: FY2026.

40entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2024-Q1 – FY20242016: 320162017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 120252026: 52026
Same theme, other companies
Upfront investment in R&D, equipment and personnel to strengthen the technological baseA theme 10 companies write about · 0 as a headwind · 10 as a tailwind

4 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「During the consolidated fiscal year, the company continued to focus on product development and recorded R&D expenses of ¥178.037 million to enhance future market competitiveness through the development of new technologies. It will continue working to strengthen R&D activities centered on the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, to enhance future market competitiveness.」

    The company disclosed consolidated-fiscal-year R&D expenses of ¥178.037 million and efforts to strengthen R&D activities centered on the Aile Matsue Lab. R&D expenses increased from ¥92.565 million in the previous year.
  2. FY2026-H1AdvancedAnnual report

    「During the six-month consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥72.170 million to enhance future market competitiveness through the development of new technologies. It will continue working to strengthen R&D activities centered on the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, to enhance future market competitiveness.」

    The company disclosed R&D expenses of ¥72.170 million for the six-month consolidated period under review and efforts to strengthen R&D activities centered on the Aile Matsue Lab. R&D expenses increased from ¥42.286 million in the same period of the previous year.
  3. FY2025AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥449.646 million. The main investment was ¥353.803 million in the development of proprietary products.」

    The company disclosed annual investments of ¥449.646 million, including ¥353.803 million in proprietary product development, updating its investment results for product development.
  4. FY2024RestatedAnnual report

    「The group conducts R&D activities involving AI-enabled data analysis and business process automation in the business systems field, as well as validation of a web-based platform for its next-generation core business package. As a result of these initiatives, the group's total R&D expenditure for the consolidated fiscal year was ¥64.631 million.」

    The company continues AI-enabled data analysis and business process automation, as well as validation of the web-based platform for its next-generation core business package, and disclosed annual R&D expenses of ¥64.631 million.
  5. FY2024-Q3RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥47.187 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, steady progress has been made in system enhancements looking ahead to the future. The company will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, system enhancements at the Aile Matsue Lab, and policy of increasing its R&D headcount. It disclosed R&D expenses of ¥47.187 million, while stating that there had been no material changes in the status of its R&D activities.
  6. FY2024-Q2RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥30.261 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses for the cumulative period through the second quarter were ¥30.261 million, and it stated that there had been no material changes in the status of its activities.
  7. FY2024-Q1RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥14.553 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥14.553 million.
  8. FY2023AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥588.801 million. The main investment was ¥395.992 million in the development of proprietary products.」

    The company disclosed capital investment of ¥588.801 million for the fiscal year ended July 2023, including ¥395.992 million in proprietary product development, updating its investment results for product development.
  9. FY2023-Q3RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥50.115 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥50.115 million.
  10. FY2023-Q2RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥34.828 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥34.828 million.
  11. FY2023-Q1RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥18.951 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥18.951 million.
  12. FY2022AdvancedAnnual report

    「During the consolidated fiscal year, the company continued to focus on product development and recorded R&D expenses of ¥68.893 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount, and disclosed annual R&D expenses of ¥68.893 million.
  13. FY2022-Q3RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥50.599 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥50.599 million.
  14. FY2022-Q2RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥32.779 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥32.779 million.
  15. FY2022-Q1RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥15.196 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. It disclosed R&D expenses of ¥15.196 million, while stating that there have been no material changes in the status of its R&D activities.
  16. FY2021AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥370.680 million. The main investment was ¥306.076 million in the development of proprietary products.」

    The company disclosed total investments of ¥370.680 million during the consolidated fiscal year, including ¥306.076 million in proprietary product development, updating its investment results for product development.
  17. FY2021-Q3RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥28.633 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥28.633 million.
  18. FY2021-Q2RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥18.385 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenditure is ¥18.385 million.
  19. FY2021-Q1RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥8.439 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are reported at ¥8.439 million.
  20. FY2020AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥549.000 million. The main investment was ¥387.727 million in the development of proprietary products.」

    The company disclosed ¥387.727 million invested in proprietary product development during the consolidated fiscal year and total capital investment of ¥549.000 million, updating the specific amount of its upfront investment in product development.
  21. FY2020-Q3RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥29.809 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenditure is ¥29.809 million, and there have been no material changes in the status of its R&D activities.
  22. FY2020-Q2RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥20.899 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will continue to increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are disclosed at ¥20.899 million.
  23. FY2020-Q1RestatedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥9.990 million to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are disclosed at ¥9.990 million.
  24. FY2019RestatedAnnual report

    「During the consolidated fiscal year, the company continued to focus on product development and recorded R&D expenses of ¥49.786 million as an upfront investment to enhance future market competitiveness through the development of new technologies. At the Aile Matsue Lab, its R&D facility in Matsue, Shimane Prefecture, it launched full-scale activities to enhance its systems using the Ruby programming language. Going forward, it will increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenses are disclosed at ¥49.786 million.
  25. FY2019-Q3AdvancedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥36.007 million as an upfront investment to enhance future market competitiveness through the development of new technologies. It also opened the Aile Matsue Lab, a new R&D facility in Matsue, Shimane Prefecture, and has been actively working to enhance its systems using the Ruby programming language. The company will continue to proactively increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount, and disclosed R&D expenses of ¥36.007 million for the cumulative consolidated period through the third quarter.
  26. FY2019-Q2AdvancedAnnual report

    「During the cumulative consolidated period under review, the company continued to focus on product development and recorded R&D expenses of ¥25.701 million as an upfront investment to enhance future market competitiveness through the development of new technologies. It also opened the Aile Matsue Lab, a new R&D facility in Matsue, Shimane Prefecture, and has been actively working to enhance its systems using the Ruby programming language. The company will continue to proactively increase its R&D headcount and strengthen its R&D activities.」

    The company continues its product development and system enhancements using Ruby at the Aile Matsue Lab, and disclosed R&D expenses of ¥25.701 million for the cumulative consolidated period through the second quarter. It also continues to indicate a policy of increasing its R&D headcount.
  27. FY2019-Q1RestatedAnnual report

    「During the six-month consolidated period, the company continued to focus on product development and recorded ¥14.968 million in research and development expenses as upfront investment to improve market competitiveness through the development of new technologies in the future. It also opened “Aile Matsue Lab” in Matsue, Shimane Prefecture, as a new research and development center and fully launched efforts to strengthen its systems using the programming language “Ruby.” Going forward, it will continue actively increasing research and development personnel and strengthening its research and development activities.」

    The company continues its product development, recognition of R&D expenses, system enhancements using Ruby at the Aile Matsue Lab, and policy of increasing its R&D headcount. R&D expenditure is reported at ¥14.968 million.
  28. FY2018AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥331.714 million. The principal investment was ¥232.04 million in the development of its own products.」

    The company disclosed investment of ¥232.04 million in the development of its own products during the consolidated fiscal year, providing a specific indication of progress in upfront investment in product development.
  29. FY2018-Q3RestatedAnnual report

    「In technology development, the company continued to focus on product development during the quarter and recorded research and development expenses as upfront investment to improve market competitiveness through the development of new technologies in the future. It also opened “Aile Matsue Lab” in Matsue, Shimane Prefecture, as a new research and development center and fully launched efforts to strengthen its systems using the programming language “Ruby.” Going forward, it plans to increase research and development personnel and strengthen its research and development activities.」

    The company continued product development, system enhancements using Ruby at Aile Matsue Lab, and its policy of increasing research and development personnel. Research and development activities for the nine-month period totaled ¥45.987 million.
  30. FY2018-Q2RestatedAnnual report

    「In technology development, the company continued to focus on product development during the quarter and recorded research and development expenses as upfront investment to improve market competitiveness through the development of new technologies in the future. It also opened “Aile Matsue Lab” in Matsue, Shimane Prefecture, as a new research and development center and fully launched efforts to strengthen its systems using the programming language “Ruby.” Going forward, it plans to increase research and development personnel and strengthen its research and development activities.」

    The company continued product development, system enhancements using Ruby at Aile Matsue Lab, and the recording of research and development expenses, and also stated its policy of increasing research and development personnel in the future.
  31. FY2018-Q1AdvancedAnnual report

    「In technology development, the company continued to focus on product development during the quarter and recorded research and development expenses as upfront investment to improve market competitiveness through the development of new technologies in the future. It also opened “Aile Matsue Lab” in Matsue, Shimane Prefecture, as a new research and development center and fully launched efforts to strengthen its systems using the programming language “Ruby.” Research and development activities for the first-quarter consolidated period totaled ¥13.996 million for the group.」

    The company opened “Aile Matsue Lab,” the research and development center in Matsue, Shimane Prefecture, whose preparation had been reported in the previous fiscal year, and fully launched efforts to strengthen its systems using Ruby. It also disclosed research and development activities of ¥13.996 million.
  32. FY2017AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥331.68 million. The principal investment was ¥271.183 million in the development of its own products. It also continued preparations to open a new research and development center in Matsue, Shimane Prefecture, and in June 2017 entered into a capital and business alliance with Sibylla Inc., which is developing blockchain technology.」

    The company specifies investments of ¥271.183 million in the development of its own products and continued preparations to open the research and development center in Matsue.
  33. FY2017-Q3AdvancedAnnual report

    「During the third quarter, the company continued to focus on product development and recorded research and development expenses as upfront investment to improve market competitiveness through the development of new technologies in the future. It was also preparing to open a new research and development center in Matsue, Shimane Prefecture, scheduled to open in October 2017.」

    The company continued upfront investment in product and new-technology development. Research and development activities for the nine-month period totaled ¥26.019 million. It also began preparations to open a new research and development center in Matsue, Shimane Prefecture, scheduled to open in October 2017.
  34. FY2017-Q2RestatedAnnual report

    「During the second quarter, the company continued to focus on product development. As upfront investment to improve market competitiveness through the development of new technologies in the future, it recorded research and development expenses. Research and development activities for the six-month consolidated period totaled ¥13.348 million for the group.」

    The company continued to focus on product development and record research and development expenses to improve market competitiveness through the development of new technologies. Research and development activities totaled ¥13.348 million.
  35. FY2017-Q1AdvancedAnnual report

    「During the first quarter, the company continued to focus on product development and actively strengthened its workforce for that purpose. As a result, development costs, personnel expenses and other costs increased. In addition, it recorded research and development expenses as upfront investment to improve market competitiveness through the development of new technologies in the future.」

    The company continued product development and headcount expansion, resulting in higher development and personnel expenses, and recorded research and development expenses to improve market competitiveness through the development of new technologies. Research and development activities totaled ¥8.1 million.
  36. FY2016AdvancedAnnual report

    「During the consolidated fiscal year, the company made investments of ¥616.124 million. The principal investments were ¥295.415 million in software for sale, including the “Aladdin Office Series,” and ¥127.1 million in interior and electrical work related to the relocation of its Osaka head office.」

    The company specifies investments of ¥616.124 million in products, software for sale and other items, including ¥295.415 million in software for sale, providing a quantitative indication of upfront investment in product development.
  37. FY2016-Q3First statedAnnual report

    「During the quarter, the company continued to focus on product development and actively expanded its workforce for that purpose. As a result, development costs, personnel expenses and other costs increased, but the company will continue strengthening its development capabilities as upfront investment for the future.」

    The company positions continued product development, headcount expansion, and increases in development and personnel expenses as upfront investment for the future.
Moved together

"Revenue and profit growth, and a stronger earnings base" moved the same way as this thread, in the same document, in 16 of its 40 moves.

16108654★123456
  1. ★This thread
  2. 1Revenue and profit growth, and a stronger earnings base16×
  3. 2Enhancing Corporate Value through Stable Earnings and Business Scale Expansion10×
  4. 3Research and Development in AI-Driven Data Analysis and Business Process Automation8×
  5. 4Focus on recurring-revenue offerings6×
  6. 5¥15 dividend per share on common stock5×
  7. 6Expansion of CROSS MALL’s Integration Functions4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for I'Ll Inc yet. It last moved in the Management Planning of 2026-09-07: "Raised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Upfront Investment in Product Development and Workforce Strengthening | I'LL INC (3854) | Komori